ARTES Biotechnology – the best way to get your recombinant product
Cell Line and Process Development based on yeast and bacteria.
Recombinant proteins as reagents.
CDMO Services
- microbial cell line and process development
- manufacturing of high quality test and preclinical material
- virus like particle vaccine development platforms
License Offer
- ready-to-use processes for enzymes, vaccines, biosimilars from ARTES’ internal development reducing time-to-market
- technology transfer and licensing of our proprietary cell lines and processes
Product Sales
- sale of antigens, enzymes and functional proteins as lab reagents
Count on us!
Our proprietary technologies have resulted in innovative products marketed worldwide. Approvals of EMA, US-FDA and of non-regulated market administrations, WHO recommendations for vaccines and GRAS certifications for food products have been achieved made with ARTES.